Correlation Between Pfizer and Demant A/S
Can any of the company-specific risk be diversified away by investing in both Pfizer and Demant A/S at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Demant A/S into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Demant AS ADR, you can compare the effects of market volatilities on Pfizer and Demant A/S and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Demant A/S. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Demant A/S.
Diversification Opportunities for Pfizer and Demant A/S
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Pfizer and Demant is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Demant AS ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Demant AS ADR and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Demant A/S. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Demant AS ADR has no effect on the direction of Pfizer i.e., Pfizer and Demant A/S go up and down completely randomly.
Pair Corralation between Pfizer and Demant A/S
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Demant A/S. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.24 times less risky than Demant A/S. The stock trades about -0.05 of its potential returns per unit of risk. The Demant AS ADR is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 1,830 in Demant AS ADR on December 28, 2024 and sell it today you would lose (10.00) from holding Demant AS ADR or give up 0.55% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Pfizer Inc vs. Demant AS ADR
Performance |
Timeline |
Pfizer Inc |
Demant AS ADR |
Pfizer and Demant A/S Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Demant A/S
The main advantage of trading using opposite Pfizer and Demant A/S positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Demant A/S can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Demant A/S will offset losses from the drop in Demant A/S's long position.Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
Demant A/S vs. CochLear Ltd ADR | Demant A/S vs. GN Store Nord | Demant A/S vs. GN Store Nord | Demant A/S vs. Siemens Healthineers AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |